Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
US Department of Justice
QuintilesIMS
Federal Trade Commission
Accenture
US Army
Moodys
Deloitte
Cipla
Farmers Insurance

Generated: August 19, 2017

DrugPatentWatch Database Preview

SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE Drug Profile

« Back to Dashboard

Which patents cover Spironolactone W/ Hydrochlorothiazide, and when can generic versions of Spironolactone W/ Hydrochlorothiazide launch?

Spironolactone W/ Hydrochlorothiazide is a drug marketed by Ivax Pharms, Lederle, Watson Labs, Parke Davis, Usl Pharma, Upsher Smith, Purepac Pharm, and Vangard. and is included in nine NDAs.

The generic ingredient in SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE is hydrochlorothiazide; spironolactone. There are thirty-one drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; spironolactone profile page.

Summary for Tradename: SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE

Patents:0
Applicants:8
NDAs:9
Bulk Api Vendors: see list1
Clinical Trials: see list457
Patent Applications: see list27
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Pharms
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
hydrochlorothiazide; spironolactone
TABLET;ORAL087004-002May 24, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Purepac Pharm
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
hydrochlorothiazide; spironolactone
TABLET;ORAL088054-001Aug 18, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
hydrochlorothiazide; spironolactone
TABLET;ORAL087948-001Feb 22, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Vangard
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
hydrochlorothiazide; spironolactone
TABLET;ORAL087655-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lederle
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
hydrochlorothiazide; spironolactone
TABLET;ORAL087511-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
US Army
Daiichi Sankyo
Citi
Johnson and Johnson
Queensland Health
Novartis
Deloitte
US Department of Justice
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot